Stockholders' Equity

12 Months Ended

Oct. 31, 2024

Stockholders' Equity Note [Abstract]

Stockholders' Equity

Note 8. Stockholders’ Equity

Analysis of Changes in Accumulated Other Comprehensive Income (Loss):

(In millions)	Foreign Currency Translation Adjustment		Derivatives		Minimum Pension Liability		Total
Balance at October 31, 2021	$	(320.3)	$	13.1	$	(34.1)	$	(341.3)
Gross change in value	(234.7)		107.4		36.6		(90.7)
Tax effect			(26.1)		(8.7)		34.8
Balance at October 31, 2022	$	(555.0)	$	94.4	$	(6.2)	$	(466.8)
Gross change in value	$	17.0	$	(9.4)	$	4.0	$	11.6
Tax effect			2.4		(1.0)		1.4
Balance at October 31, 2023	$	(538.0)	$	87.4	$	(3.2)	$	(453.8)
Gross change in value	$	76.3	$	(55.9)	$	(2.2)	$	18.2
Tax effect	—		13.4		0.5		13.9
Balance at October 31, 2024	$	(461.7)	$	44.9	$	(4.9)	$	(421.7)

Share Repurchases

In March 2017, the authorization under the 2012 Program was increased to $1.0 billion by the Company's Board of Directors. As of October 31, 2024, $256.4 million remains authorized for repurchase.

During the year ended October 31, 2024, and October 31, 2023, there were no share repurchases.

Dividends

In December 2023, the Company's Board of Directors decided to end the declaration of the semiannual dividend.

The Company paid dividends of approximately $3.0 million in each of fiscal 2023 and 2022.